The MI within the promoter of the BDNF gene (exon IV) for the first primer version was found to be significantly lower within the group of patients with MDD symptoms before the treatment when compared with the healthy subjects (Figure 2a). The gene discussed is BDNF; the disease is major depressive disorder.